Literature DB >> 28159902

IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.

Byron B Au-Yeung1, Geoffrey Alexander Smith2, James L Mueller3, Cheryl S Heyn3, Rebecca Garrett Jaszczak4, Arthur Weiss3,5, Julie Zikherman1.   

Abstract

Lymphocytes integrate Ag and cytokine receptor signals to make cell fate decisions. Using a specific reporter of TCR signaling that is insensitive to cytokine signaling, Nur77-eGFP, we identify a sharp, minimal threshold of cumulative TCR signaling required for proliferation in CD4 and CD8 T cells that is independent of both Ag concentration and affinity. Unexpectedly, IL-2 reduces this threshold in CD8 but not CD4 T cells, suggesting that integration of multiple mitogenic inputs may alter the minimal requirement for TCR signaling in CD8 T cells. Neither naive CD4 nor naive CD8 T cells are responsive to low doses of IL-2. We show that activated CD8 T cells become responsive to low doses of IL-2 more quickly than CD4 T cells, and propose that this relative delay in turn accounts for the differential effects of IL-2 on the minimal TCR signaling threshold for proliferation in these populations. In contrast to Nur77-eGFP, c-Myc protein expression integrates mitogenic signals downstream of both IL-2 and the TCR, yet marks an invariant minimal threshold of cumulative mitogenic stimulation required for cell division. Our work provides a conceptual framework for understanding the regulation of clonal expansion of CD8 T cells by subthreshold TCR signaling in the context of mitogenic IL-2 signals, thereby rendering CD8 T cells exquisitely dependent upon environmental cues. Conversely, CD4 T cell proliferation requires an invariant minimal intensity of TCR signaling that is not modulated by IL-2, thereby restricting responses to low-affinity or low-abundance self-antigens even in the context of an inflammatory milieu.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28159902      PMCID: PMC5340617          DOI: 10.4049/jimmunol.1601453

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

Review 1.  TCR signaling requirements for activating T cells and for generating memory.

Authors:  Dietmar Zehn; Carolyn King; Michael J Bevan; Ed Palmer
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

2.  Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.

Authors:  M J Barnden; J Allison; W R Heath; F R Carbone
Journal:  Immunol Cell Biol       Date:  1998-02       Impact factor: 5.126

3.  Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response.

Authors:  P R Rogers; H M Grey; M Croft
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

4.  Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase.

Authors:  N N Ahmed; H L Grimes; A Bellacosa; T O Chan; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  T cell signaling. Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansion.

Authors:  Julia M Marchingo; Andrey Kan; Robyn M Sutherland; Ken R Duffy; Cameron J Wellard; Gabrielle T Belz; Andrew M Lew; Mark R Dowling; Susanne Heinzel; Philip D Hodgkin
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

6.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 7.  Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

Authors:  Wei Liao; Jian-Xin Lin; Warren J Leonard
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

8.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

9.  Small molecule inhibition of Csk alters affinity recognition by T cells.

Authors:  Boryana N Manz; Ying Xim Tan; Adam H Courtney; Florentine Rutaganira; Ed Palmer; Kevan M Shokat; Arthur Weiss
Journal:  Elife       Date:  2015-08-24       Impact factor: 8.140

10.  Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation.

Authors:  Kristen N Pollizzi; Im-Hong Sun; Chirag H Patel; Ying-Chun Lo; Min-Hee Oh; Adam T Waickman; Ada J Tam; Richard L Blosser; Jiayu Wen; Greg M Delgoffe; Jonathan D Powell
Journal:  Nat Immunol       Date:  2016-04-11       Impact factor: 25.606

View more
  47 in total

1.  Nur77 Links Chronic Antigen Stimulation to B Cell Tolerance by Restricting the Survival of Self-Reactive B Cells in the Periphery.

Authors:  Corey Tan; James L Mueller; Mark Noviski; John Huizar; Denise Lau; Alexandra Dubinin; Ari Molofsky; Patrick C Wilson; Julie Zikherman
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

Review 2.  Tonic Signals: Why Do Lymphocytes Bother?

Authors:  Darienne R Myers; Julie Zikherman; Jeroen P Roose
Journal:  Trends Immunol       Date:  2017-07-25       Impact factor: 16.687

3.  T cell receptor and cytokine signal integration in CD8+ T cells is mediated by the protein Themis.

Authors:  Joanna Brzostek; Namrata Gautam; Xiang Zhao; Elijah W Chen; Monika Mehta; Desmond W H Tung; Yen Leong Chua; Jiawei Yap; Su H Cho; Shvetha Sankaran; Vasily Rybakin; Guo Fu; Nicholas R J Gascoigne
Journal:  Nat Immunol       Date:  2020-01-13       Impact factor: 25.606

4.  Adaptation by naïve CD4+ T cells to self-antigen-dependent TCR signaling induces functional heterogeneity and tolerance.

Authors:  Wendy M Zinzow-Kramer; Arthur Weiss; Byron B Au-Yeung
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-08       Impact factor: 11.205

5.  Caspase-8 restricts antiviral CD8 T cell hyperaccumulation.

Authors:  Yanjun Feng; Lisa P Daley-Bauer; Linda Roback; Hongyan Guo; Heather S Koehler; Marc Potempa; Lewis L Lanier; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-08       Impact factor: 11.205

Review 6.  Self-reactivity on a spectrum: A sliding scale of peripheral B cell tolerance.

Authors:  Corey Tan; Mark Noviski; John Huizar; Julie Zikherman
Journal:  Immunol Rev       Date:  2019-10-20       Impact factor: 12.988

7.  Assessment of TCR signal strength of antigen-specific memory CD8+ T cells in human blood.

Authors:  Hanchih Wu; Ashley Witzl; Hideki Ueno
Journal:  Blood Adv       Date:  2019-07-23

8.  Inhibition of IL-2 responsiveness by IL-6 is required for the generation of GC-TFH cells.

Authors:  Amber Papillion; Michael D Powell; Danielle A Chisolm; Holly Bachus; Michael J Fuller; Amy S Weinmann; Alejandro Villarino; John J O'Shea; Beatriz León; Kenneth J Oestreich; André Ballesteros-Tato
Journal:  Sci Immunol       Date:  2019-09-13

9.  The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells.

Authors:  Hilary R Keller; Hye Kyung Kim; Yuna Jo; Ronald E Gress; Changwan Hong; Jung-Hyun Park
Journal:  J Immunol       Date:  2020-05-11       Impact factor: 5.422

10.  Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4+ T Cells in Graft-versus-Host Disease.

Authors:  Jooho Chung; Vedran Radojcic; Eric Perkey; Timothy J Parnell; Yashar Niknafs; Xi Jin; Ann Friedman; Nathalie Labrecque; Bruce R Blazar; Todd V Brennan; Christian W Siebel; Ivan Maillard
Journal:  J Immunol       Date:  2019-06-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.